Resources Contact Us Home Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE     Paul Hadvary Patents Inventor: Hadvary; Paul Address: Biel-Benken, CH No. of patents: 24 Patents: Patent Number Title Of Patent Date Issued 6756364 Method of reducing gastrointestinal side effects associated with orlistat treatment June 29, 2004 A pharmaceutical combination or composition containing a lipase inhibitor, preferably orlistat, and a bile acid sequestrant is useful for treating obesity. 6703369 Lipase inhibiting compositions March 9, 2004 A pharmaceutical composition contains at least one inhibitor of lipases and at least one fatty acid ester of polyol. In this composition, the fatty acid ester has a melting point above the body temperature and the polyols are chosen from the group consisting of sugars, sugar derivatives, 6685675 Medical device adhering to the skin February 3, 2004 The present invention relates to a medical device adhering to the skin comprising a housing with a rigid base fixable on a patient's skin by means of an adhesive layer which has an adhesive surface, essentially co-extensive with the base, contacting the skin and which is fixed to the 6562329 Method of treating high plasma cholesterol levels May 13, 2003 A method prevents or treats diseases associated with high plasma cholesterol levels. In addition, this method reduces plasma cholesterol levels. The method comprises administering a lipase inhibitor, e.g. orlistat, and a pharmaceutically acceptable bile acid sequestrant. 6030953 Pharmaceutical composition containing chitosan February 29, 2000 The present invention provides orally administrable pharmaceutical compositions containing an inhibitor of gastrointestinal lipase, and at least one compound selected from the group consisting of chitosan, its derivatives and salts thereof. Methods are provided for preventing and tre 5973188 Acetic acid derivatives October 26, 1999 Acetic acid derivatives of the formula ##STR1## wherein L, M, T and Q have the significance given in the description, can be used for the treatment or prophylaxis of illnesses which are caused by the binding of adhesive proteins to blood platelets and by blood platelet aggregatio 5931814 Dermally affixed injection device August 3, 1999 An improved injection device has a casing containing an active substance reservoir, a cannula communicating with the reservoir, a device for inserting the cannula, and pump means for discharging the reservoir contents through the cannula. The cannula 11 is fixed relative to the casin 5763436 Guanidine derivatives June 9, 1998 Compounds of the formula ##STR1## wherein L, M, R, T and X are set forth in the description, as well as hydrates or solvates thereof, which inhibit thrombin-induced platelet aggregation and clotting of fibrinogen in plasma, are described. The compounds of formula I are prepared b 5747522 Amino acid derivatives May 5, 1998 N-Acyl-.alpha.-aminocarboxylic acid derivatives of the formula ##STR1## wherein L, R' to R"' and Q have the significance given in the description, can be used for the treatment or prophylaxis of illnesses which are caused by the binding of adhesive proteins to blood platelets and by 5726185 Acetic acid derivatives March 10, 1998 Acetic acid derivatives of the formula ##STR1## wherein L, M, T and Q have the significance given in the description, can be used for the treatment or prophylaxis of illnesses which are caused by the binding of adhesive proteins to blood platelets and by blood platelet aggregatio 5670515 Amino acid derivatives September 23, 1997 N-Acyl-.alpha.-aminocarboxylic acid derivatives of the formula ##STR1## wherein L, R' to R'" and Q have the definitions given in the specification, are for the treatment or prophylaxis of illnesses which are caused by the binding of adhesive proteins to blood platelets, by blood 5658928 Amino acid derivatives August 19, 1997 N-Acyl-.alpha.-aminocarboxylic acid derivatives of the formula ##STR1## wherein L, R' to R'" and Q have the significance given in the description, can be used for the treatment or prophylaxis of illnesses which are caused by the binding of adhesive proteins to blood platelets and by 5595999 Guanidine derivatives January 21, 1997 Compounds of the formula ##STR1## wherein L, M, R, T and X are set forth in the description, as well as hydrates or solvates thereof, which inhibit thrombin-induced platelet aggregation and clotting of fibrinogen in plasma, are described. The compounds of formula I are prepared b 5583133 Guanidine derivatives December 10, 1996 Compounds of the formula ##STR1## wherein L, M, R, T and X are set forth in the description, as well as hydrates or solvates thereof, which inhibit thrombin-induced platelet aggregation and clotting of fibrinogen in plasma, are described. The compounds of formula I are prepared b 5545658 Amino acid derivatives August 13, 1996 N-Acyl-.alpha.-aminocarboxylic acid derivatives of the formula ##STR1## wherein L, R' to R'" and Q have the significance given in the description, can be used for the treatment or prophylaxis of illnesses which are caused by the binding of adhesive proteins to blood platelets and by 5532232 Guanidine derivatives July 2, 1996 Compounds of the formula ##STR1## wherein L, M, R, T and X are set forth in the description, as well as hydrates or solvates thereof, which inhibit thrombin-induced platelet aggregation and clotting of fibrinogen in plasma, are described. The compounds of formula I are prepared b 5393760 Guanidine derivatives February 28, 1995 Compounds of the formula ##STR1## wherein L, M, R, T and X are set forth in the description, as well as hydrates or solvates thereof, which inhibit thrombin-induced platelet aggregation and clotting of fibrinogen in plasma, are described. The compounds of formula I are prepared b 5378712 Amino acid derivatives January 3, 1995 N-Acyl-.alpha.-aminocarboxylic acid derivatives of the formula ##STR1## wherein L, R' to R"' and Q have the significance given in the description, can be used for the treatment or control of illnesses which are caused by the binding of adhesive proteins to blood platelets and by bloo 5260307 Guanidine derivatives compositions and use November 9, 1993 Compounds of the formula ##STR1## wherein L, M, R, T and X are set forth in the description, as well as hydrates or solvates thereof, which inhibit thrombin-induced platelet aggregation and clotting of fibrinogen in plasma, are described. The compounds of formula I are prepared b 5187293 Glycerin derivatives February 16, 1993 Glycerine derivatives of the formula ##STR1## wherein the residues R.sup.1, R.sup.2 and R.sup.3 have the significance given in the description, and their hydrates, which inhibit blood platelet activating factor (PAF), are described. 5057530 Glycerol derivatives October 15, 1991 Glycerol derivatives of the formula ##STR1## wherein one of the residues R.sup.1, R.sup.2 and R.sup.3 is a group U of the formula OY.sup.1 or --X.sup.1 --CO--(A.sup.1).sub.n --Z.sup.1, another residue is a group V of the formula OY.sup.2 or --X.sup.2 --CO--(A.sup.2).sub.p --Z.sup 4863941 Glycerol derivatives September 5, 1989 Glycerol derivatives of the formula ##STR1## wherein one of the residues R.sup.1, R.sup.2 and R.sup.3 is a group U of the formula OY.sup.1 or --X.sup.1 --CO--(A.sup.1).sub.n --Z.sup.1, another residue is a group V of the formula OY.sup.2 or --X.sup.2 --CO--(A.sup.2).sub.p --Z.sup 4731373 Glycerin derivatives and inhibition of blood PAF March 15, 1988 Glycerine derivatives of the formula ##STR1## wherein the residues R.sup.1, R.sup.2 and R.sup.3 have the significance given in the description,and their hydrates, which inhibit blood platelet activating factor (PAF), are descried. 4598089 Leucine derivatives July 1, 1986 Novel compounds of the formula ##STR1## wherein A signifies the group ##STR2## or --(CH.sub.2).sub.5 --, which inhibit pancreas lipase and can be used for the control or prevention of obesity and hyperlipaemia, are disclosed. The inventive compounds can be produced by the cul       Recently Added Patents Carbon nanotube nanoelectrode arrays Write allocation based on storage system map and snapshot System and method for testing applications at the business layer Gluing wood based materials with melaminic amino resin and resorcinol or tannin resin Optical fiber with zero dispersion wavelength shifted to short wavelength region, and optical transmission line and optical transmission system using the same Radiation shield for a safety syringe having a needle sheath Methods and apparatus for representing play in a reverse mode   Randomly Featured Patents Heat treatment apparatus and method Light emitting alarm board Wheelchair lift Conveyor screw with wear-resistant members attached to its operative surface Microdevice having interior cavity with high aspect ratio surface features and associated methods of manufacture and use Vibration detector and method for rotating shaft Semiconductor storage device and portable electronic equipment having the same Mass spectrometry method with non-consecutive mass order scan Stereoselective synthesis of oxazoline derivative Microwave acoustic spectrometer © 2006. PatentGenius. All Rights Reserved.